Le Lézard
Classified in: Health, Science and technology
Subject: SVY

Report Outlines how Pharmaceutical Industry is Adjusting the Management of Medical and Commercial Advisory Board Meetings



CHAPEL HILL, N.C., Nov. 10, 2017 /PRNewswire/ -- Pharmaceutical companies have long used advisory boards to gain commercial and medical insights about products both in development and already on the market.  

But new Sunshine Act reporting requirements have forced the pharma industry to adjust how it manages advisory board meetings. To highlight current practices in managing advisory boards, consulting leader Best Practices, LLC conducted a new study focused on key aspects of planning and executing advisory boards.

While 83 percent of companies said they conduct virtual advisory boards, participants said only about 21 percent of advisory board meetings, on average, are held virtually. Virtual ad boards have a different set of criteria such as saving on travel costs and gaining rapid feedback from participants, according to the study.

The study, "Best Practices in Managing Advisory Board Meetings in the Global Market," provides information on how pharma is currently approaching issues such as how many internal stakeholders attend meetings, how insights are gathered and distributed and to whom and the percentage of medical meetings versus commercial. The research shows how companies manage their various advisory boards, as well as provides critical metrics and insights into how organizations measure the success of their advisory boards.

For this study, Best Practices, LLC engaged 12 leaders at 12 pharmaceutical companies through a benchmarking survey instrument. Executive interviews also were conducted as part of the research. 

Topics addressed in this study include:

Pharmaceutical leaders, vice presidents, directors, managers and other executives involved with the planning of advisory board meetings can utilize this study to identify the top challenges, winning strategies and best practices for successfully conducting various advisory boards and utilizing the knowledge gathered from them.

Download a complimentary report summary at: http://www.best-in-class.com/rr1472.htm.

ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.

 

SOURCE Best Practices, LLC


These press releases may also interest you

at 16:52
MEXICO CITY, Nov. 17, 2017 /PRNewswire/ -- To ensure all kids have an equal opportunity to be active, the National Football League (NFL) teamed up with Shriners Hospitals for Children® ? Mexico to host a PLAY 60 All-Ability event before this Sunday's...

at 16:49
MONTREAL, Nov. 17, 2017 /CNW Telbec/ - Once again this year, the Karnak Shriners and the Shriners Hospital for Children® - Canada will participate in the frenzy of the Santa Claus Parade this Saturday, November 18th. The Karnak Shriners are part of...

at 16:40
PALM BEACH GARDENS, Fla., Nov. 17, 2017 /PRNewswire/ -- Famous for its easy-to-follow diet plan, and for helping millions of Americans lose weight and keep it off for the past 40 years, SlimFast will introduce Advanced Energy with a new exciting TV...

at 16:40
LITCHFIELD PARK, Ariz., Nov. 17, 2017 /PRNewswire/ -- Abicenna Skin and Laser Clinic, is pleased to announce they now offer GAINSWavetm! This breakthrough noninvasive medical therapy uses low-intensity shockwave therapy to enhance sexual performance...

at 16:15
TITUSVILLE, N.J., Nov. 17, 2017 /PRNewswire/ -- A new real-world analysis of adults with type 2 diabetes and established cardiovascular disease (CVD) shows adult patients who initiated therapy with INVOKANA® (canagliflozin) or another sodium glucose...

at 16:05
JACKSONVILLE, Fla., Nov. 17, 2017 /PRNewswire/ -- TapImmune Inc. (NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian and breast cancer, today announced its Chairman and Strategic Advisor Glynn...




News published on 10 november 2017 at 15:27 and distributed by: